Sociocultural predictors of breast cancer risk perceptions in African American breast cancer survivors

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 2, 2007, Pages 244-248

  Brewster, Kiyona ^a   Wileyto, E Paul ^a   Kessler, Lisa ^a   Collier, Aliya ^a   Weathers, Benita ^a   Stopfer, Jill E ^b   Domchek, Susan ^b   Halbert, Chanita Hughes ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SURVIVOR; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC COUNSELING; HUMAN; MAJOR CLINICAL STUDY; PERCEPTION; PRIORITY JOURNAL; SOCIAL CLASS; STRUCTURED INTERVIEW;

AFRICAN AMERICANS; ATTITUDE TO HEALTH; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERVIEWS; LOGISTIC MODELS; MIDDLE AGED; PENNSYLVANIA; RISK FACTORS; SURVIVORS;

EID: 33847714624     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0481     Document Type: Article

References (50)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
2. American Cancer Society. Cancer facts and figures, 2005. Atlanta (GA): American Cancer Society; 2006.
3. Nanda R, Schumm LP, Cummings S, et al. Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 2005;294:1925-33.
4. Frank TS, Deffenbaugh AM, Reid JE, et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 2002;20:1480-90.
5. Gao Q, Tomlinson G, Das S, et al. Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer. Hum Genet 2000;107:186-91.
6. Pierce LJ, Strawderman M, Narod SA, et al. Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. J Clin Oncol 2000;18:3360-9.
7. Robson ME, Chappuis PO, Satagopan J, et al. A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment. Breast Cancer Res 2004;6:R8-17.
8. Haffty BG, Harrold E, Khan AJ, et al. Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status. Lancet 2002;359:1471-7.
9. Easton DF, Ford D, Bishop DT. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 1995;56:265-71.
10. Schwartz M, Hughes C, Roth J, et al. Spiritual faith and genetic testing decisions among high risk breast cancer probands. Cancer Epidemiol Biomarkers Prev 2000;9:381-6.
11. Halbert CH, Kessler L, Stopfer JE, et al. Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breast-ovarian cancer. Genet Med 2006;8:576-82.
12. Hughes C, Lerman C, Lustbader E. Ethnic differences in risk perception among women at increased risk for breast cancer. Breast Cancer Res Treat 1996;40:25-35.
13. Janz NK, Champion VL, Strecher VJ. The health belief model. 3rd ed. In: Glanz K, Rimer BK, Lewis FM, editors. Health behavior and health education: theory, research, and practice. San Francisco: Jossey-Bass; 2002. p. 45-66.
14. McGrath JE, Tschan F. Temporal matters in social psychology: examining the role of time in the lives of groups and individuals. Washington: American Psychological Association; 2004.
15. Koltko-Rivera ME. The psychology of worldviews. Rev Gen Psychol 2004;8:3-58.
16. Myers LJ. Understanding an Afrocentric worldview: introduction to an optimal psychology. Dubuque: Kendall-Hunt; 1988.
17. Jackson AP, Sears SJ. Implications of an Africentric worldview in reducing stress for African American women. J Couns Dev 1992;71:184-90.
18. Brown CM, Segal R. Ethnic differences in temporal orientation and its implications for hypertension management. J Health Soc Behav 1996;37:350-61.
19. Hughes C, Fasaye GA, LaSalle VH, Finch C. Sociocultural influences on participation in genetic risk assessment and testing among African American women. Patient Educ Couns 2003;51:107-14.
20. Lukwago SN, Kreuter MW, Holt CL, Steger-May K, Bucholtz DC, Skinner CS. Sociocultural correlates of breast cancer knowledge and screening in urban African American women. Am J Public Health 2003;93:1271-4.
21. Levy GA, Micco E, Putt M, Armstrong K. Value for the future and breast cancer-preventive health behavior. Cancer Epidemiol Biomarkers Prev 2006;15:955-60.
22. Donovan KA, Tucker DC. Knowledge about genetic risk for breast cancer and perceptions of genetic testing in a sociodemographically diverse sample. J Behav Med 2000;23:15-36.
23. van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000;91:1143-50.
24. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41.
25. Domchek SM, Eisen A, Calzone K, Stopfer J, Blackwood A, Weber BL. Application of breast cancer risk prediction models in clinical practice. J Clin Oncol 2003;21:593-601.
26. Marcus AC, Garrett KM, Cella D, et al. Telephone counseling of breast cancer patients after treatment: a description of a randomized clinical trial. Psychooncology 1998;7:470-82.
27. Garofalo JP, Hamann HA, Ashworth K, Baum A. Stress and quality of life in African American cancer survivors. Ethn Dis 2006;16:732-8.
28. Halbert CH, Brewster K, Collier A, et al. Recruiting African American women to participate in hereditary breast cancer research. J Clin Oncol 2005;23:7967-73.
29. Baker DL, Schuette JL, Uhlmann W. A guide to genetic counseling. New York: Wiley-Liss; 1998.
30. Lasane TP, Jones JM. Temporal orientation and academic goal setting: the mediating properties of the motivational self. J Soc Behav Pers 1999;14:31-44.
31. Lerman C, Lustbader E, Rimer B, et al. Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst 1995;87:286-92.
32. Daly MB, Lerman CL, Ross E, Schwartz MD, Sands CB, Masny A. Gail model breast cancer risk components are poor predictors of risk perception and screening behavior. Breast Cancer Res Treat 1996;41:59-70.
33. Rutten LJ, Squiers L, Hesse B. Cancer-related information seeking: hints from the 2003 Health Information National Trends Survey (HINTS). J Health Comm 2006;11:147-56.
34. Helft PR, Eckles RE, Johnson-Calley CS, Daugherty CK. Use of the internet to obtain cancer information among cancer patients at an urban county hospital. J Clin Oncol 2005;23:4954-62.
35. Holman EA, Silver RC. Getting "stuck" in the past: temporal orientation and coping with trauma. J Pers Soc Psychol 1998;5:1146-63.
36. Jones JM, Brown WT. Any time is Trinidad time! Cultural variations in the value and function of time. In: Strathman A, Joireman J, editors. Understanding behavior in the context of time: theory, research, and application. Mahwah: Lawrence Erlbaum Associates; 2005. p. 305-23.
37. McBride CM, Clipp E, Peterson BL, Lipkus IM, Demark-Wahnefried W. Psychological impact of diagnosis and risk reduction among cancer survivors. Psychooncology 2000;9:418-27.
38. Halbert CH, Kessler L, Collier A, et al. Psychological functioning in African American women at increased risk for hereditary breast and ovarian cancer. Clin Genet 2005;68:222-7.
39. Ashing-Giwa K. The recruitment of breast cancer survivors into cancer control studies: a focus on African-American women. J Natl Med Assoc 1999;91:255-60.
40. Ashing-Giwa KT, Padilla GV, Tejero JS, Kim J. Breast cancer survivorship in a multiethnic sample: challenges in recruitment and measurement. Cancer 2004;101:450-65.
41. Hughes C, Peterson SK, Ramirez A, et al. Minority recruitment in hereditary breast cancer research. Cancer Epidemiol Biomarkers Prev 2004;13:1146-55.
42. Moorman PG, Skinner CS, Evans JP, et al. Racial differences in enrolment in a cancer genetics registry. Cancer Epidemiol Biomarkers Prev 2004;13:1349-54.
43. Lerman C, Narod S, Schulman K, et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA 1996;275:1885-92.
44. Lerman C, Hughes C, Trock BJ, et al. Genetic testing in families with hereditary nonpolyposis colon cancer. JAMA 1999;281:1618-22.
45. Vernon SW. Risk perception and risk communication for cancer screening behaviors: a review. J Natl Cancer Inst Monogr 1999;25:101-19.
46. Gurmankin Levy A, Shea J, Williams SV, Quistberg A, Armstrong K. Measuring perceptions of breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006;15:1893-8.
47. McInerney-Leo A, Hadley D, Kase RG, Giambarresi TR, Struewing JP, Biesecker BB. BRCA1/2 testing in hereditary breast and ovarian cancer families III: risk perception and screening. Am J Med Genet 2006;140:2198-206.
48. Theis B, Boyd N, Lockwood G, Tritchler D. Accuracy of family cancer history in breast cancer patients. Eur J Cancer Prev 1994;3:321-7.
49. Maunsell E, Drolet M, Ouhoummane N, Robert J. Breast cancer survivors accurately report key treatment and prognostic characteristics. J Clin Epidemiol 2005;58:364-9.
50. Peters JA, Stopfer JE. Role of the genetic counselor in familial cancer. Oncology 1996;10:159-66.